Antifungal – Ayurved Healing

Neem Leaf vs Bark vs Seed Oil: Matching Plant Part to Condition

Dr. Meera Iyer — Mon, 31 Aug 2026 09:00:00 +0000

The Part-Specific Chemistry Behind Neem Medicinal Parts Research

Azadirachta indica, known in Ayurveda as Nimba, is often discussed as one medicinal substance, but classical and pharmacopoeial usage is more precise than that. The Ayurvedic Pharmacopoeia of India gives separate monographs for neem leaf, stem bark, fruit with seed, and seed, and each part has its own rasa-guna-virya-vipaka profile, constituents, dose range, and therapeutic context. The practical question is therefore not simply “does neem work?” but “which neem part, in which preparation, for which purpose, and with what safety limits?”

Neem’s bitter character links the parts together, yet the leaf, bark, and seed/oil preparations should not be treated as interchangeable. Leaf material is most commonly aligned with prameha, krimi, kushta, wound care, and oral-care applications; stem bark is more strongly framed around jvara, daha, kandu, rakta-pitta, vrana, and external decoction use; the fruit, seed, and oil-bearing fractions bring stronger limonoid and fatty-oil chemistry, making them especially relevant to topical skin, fungal, parasite, and insect-related uses.

Neem Leaf: Primary Applications and Compounds

Neem leaf is listed in the Ayurvedic Pharmacopoeia of India as the dried leaf of Azadirachta indica A. Juss., with triterpenoids and sterols as constituents. Its classical pharmacopoeial profile is tikta rasa, ruksha guna, shita virya, and katu vipaka, with actions including grahi, vatala, and pittanashaka. The API lists therapeutic uses such as jvara, krimiroga, kushta, netraroga, prameha, vrana, amashotha, and visharoga.

Modern phytochemical descriptions of neem leaf include flavonoids such as quercetin and kaempferol, along with limonoids and related compounds such as nimbolide, nimbin-family constituents, and azadirachtin-related compounds. The exact profile depends on the plant material, extraction solvent, and manufacturing method, so a fresh leaf paste, decoction, hydroalcoholic extract, and standardized capsule should not be assumed to deliver the same chemistry.

Best-aligned leaf applications:

Prameha and blood-glucose support: Aqueous neem leaf-and-twig extract has been evaluated in people with type 2 diabetes already using metformin, with doses of 125 mg, 250 mg, or 500 mg twice daily for 12 weeks. This supports a practitioner-supervised role for leaf/twig extract in metabolic support, not a replacement for prescribed diabetes care.
Dental plaque and gingival care: Neem mouthrinses have been evaluated in randomized oral-care trials and reviews comparing them with chlorhexidine-based rinses. The strongest practical use is as an adjunct to brushing, flossing, and professional dental care.
Topical wound and skin hygiene: Leaf preparations are classically linked with vrana, kushta, and krimi. Laboratory work also describes antibacterial activity of neem leaf extracts against organisms including Staphylococcus aureus and MRSA, which supports topical-hygiene use while not replacing medical treatment for infected wounds.

Neem Stem Bark: Primary Applications and Compounds

Neem stem bark is a distinct pharmacopoeial drug, not simply “stronger neem.” The Ayurvedic Pharmacopoeia of India lists neem stem bark as the stem bark of Azadirachta indica A. Juss., with bitter principles including nimbin and nimbiol. Its profile is tikta rasa, laghu and ruksha guna, shita virya, and katu vipaka, with actions including kandughna, kaphahara, pittahara, vishaghna, vranashodhanakara, and hridayavidahashantikara.

The API’s listed therapeutic uses for neem stem bark include daha, jvara, krimiroga, kandu, kushta, prameha, rakta pitta, and vrana. This makes bark especially relevant where the clinical picture is described in Ayurvedic language as heat, itching, pitta-kapha involvement, skin irritation, wound cleansing, or febrile patterns. The API also notes important formulations such as Sudarshana Churna, Nimbadi Kvatha Churna, Panchanimba Churna, Panchatikta Guggulu Ghrita, and Pathyadi Kvatha Churna.

Best-aligned bark applications:

Jvara and daha patterns: Bark is pharmacopoeially linked with fever and burning presentations, especially when selected by an Ayurvedic practitioner within a broader diagnosis.
Kandu, kushta, and vrana: Bark’s listed actions of kandughna and vranashodhanakara support its use in itching, skin, and wound-cleansing contexts.
External decoction use: The API gives neem stem bark powder at 2–4 g and specifically notes that the decoction should be used externally, making external cleansing and wash preparations more pharmacopoeially grounded than broad claims for internal liver therapy.

Neem Fruit, Seed, and Seed Oil: Primary Applications and Compounds

The fruit-and-seed portion of neem has a different therapeutic personality because it carries fixed oil and limonoid chemistry. The Ayurvedic Pharmacopoeia of India lists the whole dried fruit including seeds as containing fixed oil with diterpenoids and triterpenoids known as limonoids, including nimbin, gedunin, azadirachtin, nimbidinin, and salanin. The separate seed monograph lists fatty oil and amino acids, with rasa described as kashaya, tikta, and katu; guna as laghu, snigdha, and sara; virya as ushna; and vipaka as katu.

Because of this oil-rich and limonoid-rich profile, seed and seed-oil preparations are most relevant to topical skin, fungal, insect, and parasite-related contexts. The API lists fruit/seed uses including krimi, kushta, prameha, vrana, shotha, and related disorders, while the seed monograph includes dadru, pama, kandu, tvagroga, krimi, and vrana.

A randomized double-blind clinical trial compared 5% neem seed extract cream with 1% clotrimazole cream in localized tinea corporis and/or tinea cruris over four weeks. The neem seed extract group had an effective cure rate of 66.67%, while the clotrimazole group had 80%; two adverse effects occurred in the neem group and none in the clotrimazole group. This supports a cautious topical role for neem seed extract in localized dermatophyte contexts, while standard antifungal diagnosis and treatment remain important.

Plant Part	Key Pharmacopoeial / Phytochemical Notes	Best-Aligned Uses	Dose / Application Notes	Clinical Use Caution
Leaf	API: triterpenoids and sterols; literature: quercetin, kaempferol, nimbolide, nimbin-family compounds	Prameha support, dental plaque/gingival care, topical wound and skin hygiene	API: 1–3 g powder; 10–20 ml decoction. Clinical extracts use product-specific dosing.	Monitor blood glucose if using diabetes medicines; do not replace prescribed care.
Stem Bark	API: bitter principles nimbin and nimbiol; tikta, laghu-ruksha, shita, katu profile	Jvara, daha, kandu, kushta, rakta-pitta, vrana-cleansing contexts	API: 2–4 g powder; decoction should be used externally.	Better framed as a practitioner-selected bark drug, not a generic liver supplement.
Fruit / Seed / Seed Oil	API fruit: fixed oil with limonoids including nimbin, gedunin, azadirachtin, nimbidinin, salanin; API seed: fatty oil and amino acids	Topical fungal and parasite-related skin contexts; krimi, dadru, pama, kandu, tvagroga	Topical preparations are preferred for public use; 5% seed extract cream has been clinically compared with clotrimazole for localized tinea corporis/cruris.	Do not self-administer neem oil orally; keep away from children and pregnancy.

Important Caveats and Safety Profile

Neem safety is also part-specific. Leaf powder, bark decoction, seed extract cream, and neem oil do not carry the same risk profile. Neem oil ingestion has been associated with vomiting, seizures, metabolic acidosis, toxic encephalopathy, and serious pediatric poisoning. For this reason, neem oil should not be self-administered by mouth, should be kept away from children, and should not be used internally during pregnancy or lactation.

Fertility is another important caution. The API seed monograph includes garbhanirodhaka among its actions, and experimental contraceptive literature describes spermicidal and anti-fertility activity from neem oil and related seed preparations. People trying to conceive, pregnant women, and lactating women should avoid therapeutic neem use unless directly supervised by a qualified clinician.

People taking insulin, sulfonylureas, metformin combinations, or other glucose-lowering medicines should use neem only with blood-glucose monitoring and professional guidance. Neem leaf/twig extracts have been evaluated for glycemic support, so combining them casually with diabetes medicines can increase the chance of unwanted low blood sugar.

Applying the Evidence in Clinical Practice

A part-specific approach is the safest way to use neem. For oral hygiene, leaf-based mouthrinse or dental preparations fit the available oral-care data. For prameha-type metabolic support, standardized leaf/twig extract belongs under medical monitoring. For itching, wound cleansing, feverish heat, and skin irritation, leaf and stem bark should be selected according to the Ayurvedic diagnosis and route of use. For localized dermatophyte infections such as tinea corporis or tinea cruris, seed extract cream has more relevant clinical support than bark or ordinary leaf tea, but diagnosis and antifungal care remain essential.

For broader Ayurvedic reasoning, neem should be integrated into a full assessment of dosha, dhatu, agni, rakta involvement, skin presentation, bowel pattern, medications, and patient strength. For conditions involving systemic channel health alongside neem-based protocols, see our related article on the srotas system and body channel health.

Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Consult a qualified Ayurvedic practitioner or healthcare provider before starting neem, especially if you are pregnant, trying to conceive, treating a child, using diabetes medication, managing a skin infection, or considering internal use.

References

Cassia Tora (Chakramarda): The Underrated Skin and Liver Herb in Ayurvedic Texts

Dr. Meera Iyer — Fri, 17 Jul 2026 09:00:00 +0000

Among the less widely marketed herbs of Ayurvedic materia medica, Cassia tora Linn. occupies a distinctive position. In classical and pharmacopoeial usage it is known by names such as Chakramarda, Prapunnada, Edagaja, and Dadrughna; the last name itself points to its valued role in dadru, the ring-shaped itchy skin disorder commonly correlated with tinea-like presentations. The dried seed is listed in the Ayurvedic Pharmacopoeia of India as Prapunnada, with “Ring Worm Plant” and “Fetid Cassia” as English names, and its main actions are centred on skin, itching, worms, constipation, and Kapha-Vata disorders.

The herb’s modern phytochemical profile fits this traditional focus. Cassia tora contains anthraquinones, naphthopyrone glycosides, flavonoids, fixed oil, and related phenolic constituents. These include chrysophanol, emodin, rhein, physcion, aloe-emodin, cassiaside, rubrofusarin derivatives, torachrysone, and toralactone-related compounds. This makes Chakramarda especially relevant in a practical Ayurvedic discussion of stubborn itching, recurrent fungal-type skin complaints, thickened or scaly skin conditions, short-term constipation support, and carefully supervised liver-support contexts.

Classical Identity and Ayurvedic Profile

The Ayurvedic Pharmacopoeia of India describes Prapunnada as the dried seed of Cassia tora Linn., an annual herb occurring as a weed throughout India’s plains and ascending to the Central Himalayas. The official seed monograph gives its rasa as katu, guna as laghu and ruksha, virya as ushna, and vipaka as katu. Its listed karmas include rechana, Kapha-Vata-shamaka, krimighna, lekhana, kushthaghna, vishaghna, varnaprasadakara, and tvachya.

This profile explains why Chakramarda is not merely a “skin herb” in a cosmetic sense. Katu rasa, laghu-ruksha guna, and ushna virya make it drying, scraping, warming, and Kapha-reducing. In classical Ayurvedic terms, this is useful where itching, circular lesions, dampness, heaviness, oozing tendency, thickening, or Kapha-Vata involvement dominates. The API therapeutic indications include kushtha, vrana vikara, dadru, vibandha, gulma, krimi, pama, kandu, shvasa, and kasa.

Phytochemical Profile

The seed monograph of Prapunnada lists anthraquinones and fixed oil as constituents. Broader phytochemical reviews of Cassia tora describe different constituents in seeds, leaves, roots, and flowers, with seeds especially rich in anthraquinone and naphthopyrone derivatives. The important point for Ayurvedic use is that the plant contains compounds relevant to itching, fungal-type skin complaints, laxative action, antioxidant pathways, and inflammatory skin models, while still requiring conservative dosing.

Anthraquinones: Seeds and leaves contain compounds such as chrysophanol, emodin, physcion, rhein, aloe-emodin, and related derivatives. Chrysophanic acid-9-anthrone has been identified in the literature as an important antifungal principle of Cassia tora, and anthraquinone-rich fractions have been associated with antifungal and antibacterial activity in laboratory contexts.
Emodin: Emodin is a naturally occurring anthraquinone found in several medicinal plants, including Cassia tora. Its pharmacological profile includes anti-inflammatory, antimicrobial, antioxidant, hepatoprotective, and antiproliferative activity in experimental models. In an Ayurvedic herb article, this supports Chakramarda’s relevance to inflammatory and chronic skin discussions without turning it into a cancer or metabolic-disease remedy.
Naphthopyrone glycosides: Cassiaside, rubrofusarin-6-O-β-D-gentiobioside, and related naphthopyrone glycosides have been isolated from the seeds. Some seed glycosides have been evaluated for antihepatotoxic and antioxidant-type activity, making the liver-support discussion plausible only within supervised, non-emergency use.
Flavonoids: Leaves contain flavonoid derivatives including quercetin- and luteolin-related compounds. These are relevant to the discussion of scaly and inflammatory skin conditions, particularly where topical formulations are considered by a practitioner.
Fixed oil and seed gum: The seed contains fixed oil and polysaccharide-rich material. These constituents contribute more to the pharmacognostic and formulation identity of the seed than to a simple single-compound explanation of its action.

Ayurvedic Applications

Chakramarda is best understood as a focused herb for Kapha-Vata skin disorders with itching, ring-like lesions, roughness, scaling, or parasitic association, with a secondary role as a short-term rechana herb. It should not be presented as a broad daily supplement. Its potency lies in targeted use, correct preparation, correct diagnosis, and short, practitioner-guided courses.

Fungal-Type Skin Complaints and Dadru

Dadru is the most characteristic application of Chakramarda. The pharmacopoeial synonym Dadrughna, the English name “Ring Worm Plant,” and the API indication of dadru all point to this primary use. Classical lepa-style applications use Chakramarda seed or related combinations externally in skin disorders, while modern phytochemistry identifies anthraquinones and chrysophanic acid-9-anthrone as relevant constituents for antifungal-type activity.

In practice, powdered seed may be prepared as a paste with clean water or a classical sour medium when prescribed, then applied locally for a limited period under guidance. The skin should not be aggressively abraded, covered tightly, or treated repeatedly if burning, blistering, spreading redness, pus, fever, or worsening irritation appears. A circular rash is not always simple ringworm, so persistent or recurrent lesions require medical diagnosis.

Itching, Pama, and Kapha-Type Skin Irritation

The API lists kandu and pama among Prapunnada’s therapeutic uses, and its karmas include kushthaghna, krimighna, lekhana, and tvachya. This makes Chakramarda suitable in traditional formulations where itching is associated with Kapha accumulation, dampness, rough eruptions, or suspected parasitic involvement. It is usually more appropriate for moist, itchy, Kapha-dominant presentations than for very dry, cracked, highly inflamed Pitta-Vata skin.

External preparations may be chosen as paste, medicated oil, or compound lepa depending on the condition. Internal use, when needed, is usually kept within the classical powder dose and combined with diet, hygiene, bowel regulation, and other herbs according to the practitioner’s assessment.

Psoriasis-Like Scaling and Kitibha-Type Presentations

Chakramarda appears in traditional discussions of chronic skin disease, including thickened or scaly presentations such as kitibha. Experimental work with Cassia tora leaf extracts and isolated flavonoids has also been directed at psoriasis-like skin models. This supports its inclusion in practitioner-designed external formulations for scaly, itchy, chronic lesions, but it does not justify unsupervised internal treatment for psoriasis.

For psoriasis-like disease, Chakramarda is usually only one part of a wider plan. Ayurveda considers digestion, bowel habit, diet, incompatible foods, stress, chronic inflammation, and dosha involvement. Conventional assessment is important when plaques are widespread, painful, infected, bleeding, associated with joint pain, or not clearly diagnosed.

Liver-Support Context

Cassia tora leaf and seed preparations have shown hepatoprotective activity in experimental liver-injury models, including carbon tetrachloride and galactosamine-related models. The relevant constituents include anthraquinones, naphthopyrone glycosides, and antioxidant phenolics. This gives Chakramarda a reasonable place in a cautious pharmacognosy discussion of liver-support herbs, but not as a self-treatment for jaundice, hepatitis, fatty liver disease, or abnormal liver tests.

Any visible jaundice, dark urine, pale stools, persistent nausea, right upper abdominal pain, fever, swelling, unexplained weight loss, or abnormal liver enzymes requires evaluation by a physician. If Chakramarda is used in a liver-support context, it should be part of a qualified practitioner’s plan with attention to dose, duration, bowel effects, and medication interactions.

Short-Term Constipation Support

The API lists rechana as a karma and vibandha as a therapeutic use of Prapunnada. This supports its traditional role in constipation, especially where Kapha-Vata obstruction, heaviness, sluggishness, and skin complaints coexist. The seed should not be treated as a casual daily laxative; anthraquinone-containing laxatives are generally intended for short-term use.

For adults, the API dose for Prapunnada seed powder is 1–3 g. The lowest effective dose is preferred, and prolonged use should be avoided because stimulant-laxative patterns can aggravate dependency, cramping, diarrhoea, dehydration, and electrolyte imbalance. Constipation with severe abdominal pain, vomiting, blood in stool, unexplained weight loss, or sudden bowel change needs medical assessment.

Preparation and Dosage Guide

The safest public guidance is to stay close to the official pharmacopoeial dose and to distinguish between external and internal use. Classical formulas vary by disease, vehicle, and processing method; therefore, concentrated extracts, capsules, and proprietary products should not be dosed by simply converting the crude-powder dose.

Use Context	Traditional Rationale	Common Preparation	Conservative Adult Guidance
Dadru / ring-shaped itchy lesions	Dadrughna, Kushthaghna, Kandughna	Seed paste or compound lepa	External use under guidance; stop if irritation worsens
Kandu, Pama, Kapha-type itching	Krimighna, Lekhana, Tvachya	Paste, medicated oil, or compound external preparation	Use after diagnosis; avoid broken or severely inflamed skin unless prescribed
Kitibha-like scaling	Kushthaghna, Lekhana, Kapha-Vata-shamaka	External formulation as part of a wider plan	Practitioner-supervised; not a stand-alone psoriasis treatment
Vibandha / short-term constipation	Rechana	Seed powder	1–3 g powder; short-term use only
Krimi or Gulma-type indications	Krimighna, Lekhana, Kapha-Vata-shamaka	Powder or compound formulation	Internal use only with qualified Ayurvedic supervision
Liver-support context	Antioxidant and hepatoprotective pharmacological profile	Practitioner-selected formulation	Never self-treat jaundice or abnormal liver tests

Safety and Contraindications

Chakramarda is a potent medicinal herb, not a routine wellness powder. Because the seed contains anthraquinone-type constituents and has rechana action, internal use should be conservative, short-term, and avoided in unsuitable patients. External use can also irritate sensitive skin if applied too strongly or too frequently.

Pregnancy and breastfeeding: Avoid internal use unless a qualified physician specifically advises otherwise.
Children: Avoid unsupervised internal use in children; anthraquinone laxative sensitivity is higher in younger age groups.
Inflammatory bowel disease or bowel obstruction: Avoid in active Crohn’s disease, ulcerative colitis, intestinal obstruction, severe dehydration, unexplained abdominal pain, or suspected appendicitis.
Diarrhoea or dehydration: Do not use internally when loose stools, dehydration, electrolyte imbalance, or severe weakness is present.
Kidney disease, heart disease, or diuretic use: Use only with medical supervision because laxative-induced fluid and electrolyte shifts may be risky.
Liver disease: Do not self-treat jaundice, hepatitis, fatty liver disease, cirrhosis, or abnormal liver enzymes with Chakramarda.
Skin diagnosis: Do not assume every circular, itchy, or scaly lesion is fungal. Persistent lesions, bleeding lesions, changing moles, non-healing ulcers, pus, fever, or spreading redness require medical evaluation.
Duration: Avoid long-term oral use; stimulant-laxative patterns are best reserved for short courses under guidance.

Nothing in this article diagnoses, treats, or cures a medical condition. Chakramarda should be used under the guidance of a qualified Ayurvedic practitioner or healthcare provider, especially if pregnant, breastfeeding, treating a child, managing chronic skin disease, liver disease, bowel disease, kidney disease, or taking medication.